From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
For example, some beers have a higher alcohol content, affecting how much alcohol you consume from one drink
Some individuals use MICC to assist with energy production and muscle recovery as part of a weight management plan
When that skin rubs against itself, it can create small abrasions where that bacteria can enter the skin and create an infection
The teams support is unmatched
Depending on the nutrient, effects can last from several days to a few weeks
